Previous Close | 0.0003 |
Open | 0.0003 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0002 - 0.0003 |
52 Week Range | 0.0002 - 0.0020 |
Volume | |
Avg. Volume | 44,113,182 |
Market Cap | 550,737 |
Beta (5Y Monthly) | 118.03 |
PE Ratio (TTM) | 0.00 |
EPS (TTM) | 0.1150 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The First Stage of Transition Into the “Content Plus Product” Entity To Be Deployed in Fourth Quarter of 2022Houston, May 10, 2022 (GLOBE NEWSWIRE) -- Houston, Texas, 05/10/2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today that it officially commenced its transition into “Content Plus Product Company” initially
Houston , Texas, May 03, 2022 (GLOBE NEWSWIRE) -- Houston, Texas,05.03/ 2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today that the Company ended 2021 with a record sale surpassing $1Million as reported in Annual Report . 2021. This marks the fifth consecutive Positive Revenues Year . This positive trend is exten
Monetizing 2022 OpportunitiesHouston, Feb. 28, 2022 (GLOBE NEWSWIRE) -- February 28, 2022. Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content targeting dermatological and other health and wellness concerns, shares a Shareholders Update Letter from the CEO, Dr. Agnes Olszewski. To our Valued ShareholdersThe times are